Trial Profile
Effect of agomelatine in patients with major depressive disorder.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Feb 2015
Price :
$35
*
At a glance
- Drugs Agomelatine (Primary)
- Indications Major depressive disorder
- Focus Adverse reactions; Therapeutic Use
- 03 Feb 2015 New trial record